Clinical Trial Update: Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating systemic corticosteroids for treatment of post-COVID-19 interstitial lung disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Turkish Thoracic Society | Conditions: Covid19, COVID-19 Pneumonia | Phase 4 | Status: COMPLETED